Ospemifene
Last Updated: 06/30/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 268 publications
Long-term effects of ospemifene on densitometric and bone metabolism biomarkers in postmenopausal women reporting Vulvar and Vaginal Atrophy (VVA).
Journal: BMC women's health
Published: January 12, 2026
A computationally informed framework for lipid-based formulation developability: Integrating predictive models with case studies.
Journal: Journal of pharmaceutical sciences
Published: December 22, 2025
Case-Based Perspectives on the Management of Genitourinary Syndrome of Menopause.
Journal: Clinics and practice
Published: December 03, 2025
Treating Genitourinary Syndrome of Menopause in Postmenopausal Women with a History of Breast Cancer.
Journal: Drugs & aging
Published: September 19, 2025
Hormone replacement therapy in gynecologic cancer: oncologic safety and alternative therapies.
Journal: International journal of gynecological cancer : official journal of the International Gynecological Cancer Society
Published: September 15, 2025
Treatment of Menopausal Symptoms When Hormone Therapy Is Contraindicated.
Journal: Seminars in reproductive medicine
Published: September 02, 2025
Treatment of vulvovaginal atrophy is associated with high levels of satisfaction and improves symptom severity and patient-reported outcomes: 12-month results of the PatieEnt satisfactiON studY (PEONY).
Journal: Menopause (New York, N.Y.)
Published: August 01, 2025
Ospemifene May Provide Better Results Than Other Approaches to Treat Some Vaginal Symptoms of Menopause.
Journal: American family physician
Published: June 18, 2025
Treatment patterns for genitourinary syndrome of menopause: a TriNetX analysis.
Journal: The Canadian journal of urology
Published: May 07, 2025
State of the art in menopause: current best practice approaches from the IMS World Congress 2024, Melbourne.
Journal: Climacteric : the journal of the International Menopause Society
Published: February 10, 2025
Treating VVA improves symptom severity and patient-reported outcomes: 6-month PEONY results.
Journal: Climacteric : the journal of the International Menopause Society
Published: February 07, 2025
Quality of life and Satisfaction With Ospemifene for Treating Vulvovaginal Atrophy in Breast Cancer Survivors: Six-Month Results From the PatiEnt SatisfactiON StudY (PEONY).
Journal: Clinical breast cancer
Published: January 29, 2025
Last Updated: 06/30/2026